CN113403329A - 一种用于猫冠状病毒的rna疫苗及其构建方法 - Google Patents

一种用于猫冠状病毒的rna疫苗及其构建方法 Download PDF

Info

Publication number
CN113403329A
CN113403329A CN202110531256.5A CN202110531256A CN113403329A CN 113403329 A CN113403329 A CN 113403329A CN 202110531256 A CN202110531256 A CN 202110531256A CN 113403329 A CN113403329 A CN 113403329A
Authority
CN
China
Prior art keywords
seq
val
leu
thr
rna vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202110531256.5A
Other languages
English (en)
Other versions
CN113403329B (zh
Inventor
刘昕
赖强
王弋
吴培枫
陈怡林
郑飞
吴先戈
欧海航
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dongguan Bosheng Biological Technology Co ltd
Original Assignee
Dongguan Bosheng Biological Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dongguan Bosheng Biological Technology Co ltd filed Critical Dongguan Bosheng Biological Technology Co ltd
Priority to CN202110531256.5A priority Critical patent/CN113403329B/zh
Publication of CN113403329A publication Critical patent/CN113403329A/zh
Application granted granted Critical
Publication of CN113403329B publication Critical patent/CN113403329B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/20011Coronaviridae
    • C12N2770/20022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

本发明属于RNA疫苗的技术领域,具体涉及一种用于猫冠状病毒的RNA疫苗及其构建方法。所述RNA疫苗为采用含有5’UTR、S蛋白、终止密码子、3’UTR以及polyA核酸的序列合成;所述S蛋白选自FCoV‑I型或FCoV‑II型;所述5’UTR、3’UTR的序列选取自猫源的猫血红蛋白或猫白蛋白,所选序列的同源性在50%~100%;本发明的RNA疫苗能够实现同时诱导细胞免疫和体液免疫,可以做到无细胞生产、且生产时无需导入有毒化学品,能够高效迅速地对付病毒变异,相较传统疫苗,本发明的用于猫冠状病毒的RNA疫苗能够有效地缩短疫苗研发和生产周期,为防控FCoV的爆发提供有效的技术手段。

Description

一种用于猫冠状病毒的RNA疫苗及其构建方法
技术领域
本发明属于RNA疫苗的技术领域,具体涉及一种用于猫冠状病毒的RNA疫苗及其构建方法。
背景技术
猫冠状病毒(Feline coronavirus,FCoV)是家猫和野生猫致死性疾病猫传染性腹膜炎(Feline infectious peritonitis,FIP)的病原,通过口鼻传播,主要感染幼年和老龄猫,在世界猫群中广泛流行。
FCoV病毒有4种主要结构蛋白,分别是刺突蛋白(Spike protein,S)、膜蛋白(Membrane protein,M)、小膜蛋白(Small envelope protein,E)和核衣壳蛋白(Nucleocapsid protein,N)。其中S蛋白是排列在包膜突起的糖蛋白,分子量约为180~200kDa,它对于诱导宿主的抗体应答和细胞免疫很重要。冠状病毒可通过S蛋白与特定的细胞受体结合,是决定病毒致病性和组织嗜性的关键因素,S蛋白是诱导机体产生中和抗体的保护性抗原,目前疫苗的相关研究的也集中在S蛋白区域。
FCoV根据S蛋白氨基酸序列和抗体交叉中和差异分为2种血清型:I型和II型。血清I型是主要流行毒株类型,其S蛋白完全来源于FCoV。血清II型FCoV临床不常见,由犬冠状病毒(Canine coronavirus,CCoV)和FCoV双重重组而来。FCoV-І型在世界范围内广泛流行,在美国和欧洲一些国家,FCoV-І型毒株感染率高达80-95%;在亚洲地区主要流行FCoV-ІІ型,感染率高达25%。血清I型和II型 FCoV毒株均存在2种在抗原和形态学上不同的生物型(或病理型):猫肠道冠状病毒(Feline enteric coronavirus,FECV)和猫传染性腹膜炎病毒(Feline infectious peritonitis virus,FIPV)。
其中猫肠道冠状病毒(FECV)的感染仅局限于消化道,会引起猫的体温上升,食欲不振甚至脱水等症状,致死率较低。猫传染性腹膜炎病毒,是猫肠道冠状病毒的高毒力突变株,具有高传染性及高致死率的特点。在临床上,猫传染性腹膜炎又可以分为渗出性和非渗出性两种病理型。由于暂无有效治疗药物,携带FIPV的猫咪一旦发病,难以康复,死亡率高。
近年来我国养猫数量逐年增加,由于国内市场并无相关疫苗,猫感染FIP的风险与日俱增。FECV及其转化的FIPV基因型毒株中存在由不同程度的单核苷酸多态性和插入/缺失现象,同时FIP潜伏期几周至几年不等,这种巨大差异给防疫工作带来严峻挑战。目前针对FIPV感染猫的治疗只能起到延缓疾病的作用,不能达到根治的效果,所以疫苗的预防显得尤为重要。
国内外现有疫苗的大都还处于研究阶段,由于该病毒特殊的感染机制,使得常规疫苗和重组疫苗效果不佳。FECV及其转化的FIPV基因型毒株中存在由不同程度的单核苷酸多态性和插入/缺失现象。FECV感染率达80%-95%,而FIP的致死率高达95%,目前并没有有效的疫苗上市,猫一旦感染FIPV几乎只能靠治疗延缓死亡,因此,FCoV疫苗的市场很有潜力,并且对FCoV预防具有重要意义。前期疫苗的研究FIP减毒活疫苗、灭活疫苗和亚单位疫苗免疫猫后均可观察到ADE,使FIP潜伏期缩短至1-2 d,病程更短,死亡更快。随着基因工程技术和分子生物学技术的发展,人们开始把注意力活载体疫苗及核酸疫苗等新型基因工程疫苗上。
发明内容
针对上述问题,本发明的目的在于提供一种用于猫冠状病毒的RNA疫苗及其构建方法,选取特定的5’UTR、3’UTR、S蛋白、终止密码子、polyA核酸序列,构建得到FCoV的RNA疫苗,将其转染细胞后能够高效表达,免疫动物后能够产生高水平的抗体,该抗体具有较高的中和效价及滴度。
本发明的技术内容如下:
本发明提供了一种用于猫冠状病毒的RNA疫苗,所述RNA疫苗为采用含有5’UTR、S蛋白、终止密码子、3’UTR以及polyA核酸的序列合成;
所述S蛋白选自FCoV-I型或FCoV-II型;
所述疫苗还包括纳米脂质颗粒,所述纳米脂质颗粒包裹RNA疫苗;
所述纳米脂质颗粒包括BHEM-Chol、PEG5k-b-PLGA11k、PLGA11k聚合物的混合物;
所述5’UTR、3’UTR的序列选取自猫源的猫血红蛋白或猫白蛋白,所选序列的同源性在50%~100%;
所述5’UTR、3’UTR分别选自六组不同的猫血红蛋白或猫血清白蛋白,其核酸序列分别为序列表SEQ ID NO.1和SEQ ID NO.2、SEQ ID NO.3和SEQ ID NO.4、SEQ ID NO.5和SEQ ID NO.6、SEQ ID NO.7和SEQ ID NO.8、SEQ ID NO.9和SEQ ID NO.10、SEQ ID NO.11和SEQ ID NO.12所示的六组;
所述5’UTR、3’UTR的六组序列选自GenBank中NCBI参考序列XM_023246781.1、XM_011290755.3、XM_003992859.2、XM_003992882.4、XM_003998693.4、X84842.1;
所述猫冠状病毒的S蛋白,其氨基酸序列如序列表SEQ ID NO.13所示,其核酸序列如序列表SEQ ID NO.14所示;
所述RNA疫苗的核酸序列包括如序列表SEQ ID NO.15~20所示;
所述终止密码子为TGA、TAA、TAG的自由组合,个数为1-10个;
所述polyA中的碱基A的个数为1-200个。
本发明还提供了一种用于猫冠状病毒的RNA疫苗的构建方法,包括如下步骤:
选取5’UTR、3’UTR、S蛋白、终止密码子、polyA核酸序列合成RNA疫苗的核酸序列构建于载体上,转染到细菌得到重组菌,将重组菌进行质粒提取得到重组质粒,将重组质粒进行酶切、转录、纯化得到RNA疫苗核酸,所述RNA疫苗的核酸序列如序列表SEQ ID NO.15~20所示;
所述S蛋白选自FCoV-I型或FCoV-II型;
所述RNA疫苗包括由脂质纳米颗粒载体包裹,所述脂质纳米颗粒的制备原料包括聚合物PEG5k-b-PLGA11k、PLGA11k和BHEM-Chol;
所述脂质纳米颗粒包裹RNA疫苗的操作为:将RNA疫苗核酸溶液与BHEM-Chol、PEG5k-b-PLGA11k、PLGA11k混合,超声得到油相-水相的初乳液,加入无核酸酶水再超声乳化得到水相-油相-水相的复乳液,将复乳液中的有机溶液去除,浓缩,即得到脂质纳米颗粒包裹的RNA疫苗;
所述RNA疫苗核酸溶液为RNA疫苗核酸使用无核酸酶水溶解得到;
所述BHEM-Chol、PEG5k-b-PLGA11k、PLGA11k使用之前分别溶于色谱级三氯甲烷溶液中。
本发明的有益效果如下:
本发明的用于猫冠状病毒的RNA疫苗,为通过选取特定的5’UTR、3’UTR、S蛋白、终止密码子、polyA核酸序列,构建得到FCoV的RNA疫苗,将其转染细胞后能够高效表达,免疫动物后能够产生高水平的抗体,该抗体具有较高的中和效价及滴度;
本发明的RNA疫苗能够实现同时诱导细胞免疫和体液免疫,可以做到无细胞生产、且生产时无需导入有毒化学品,能够高效迅速地对付病毒变异,相较传统疫苗,本发明的用于猫冠状病毒的RNA疫苗能够有效地缩短疫苗研发和生产周期,为防控FCoV的爆发提供有效的技术手段;
本发明的RNA疫苗的构建,成本低,生产效率高,因制造速度快,受微生物污染的几乎也相对较低,RNA疫苗的安全性相对较高,制备脂质纳米颗粒作为RNA疫苗的运送载体,脂质纳米颗粒具有核酸包封率高,能够有效转染,组织穿透性增强,细胞毒性和免疫原性低等特点,细胞转染后的脂质纳米颗粒FCoV-S-mRNA能够高效表达。
附图说明
图1为RNA疫苗核酸的凝胶电泳图;
图2为RNA疫苗的体外表达试验SDS-PAGE以及Western blot结果图;
图3为RNA疫苗的抗体水平检测结果图;
图4为RNA疫苗中和抗体滴度的测定结果图。
具体实施方式
以下通过具体的实施案例以及附图说明对本发明作进一步详细的描述,应理解这些实施例仅用于说明本发明而不用于限制本发明的保护范围,在阅读了本发明之后,本领域技术人员对本发明的各种等价形式的修改均落于本申请所附权利要求所限定。
若无特殊说明,本发明的所有原料和试剂均为常规市场的原料、试剂。
实施例
一种用于猫冠状病毒的RNA疫苗及其构建:
1.重组菌构建:
选取5’UTR、3’UTR、S蛋白(FCoV-I型中的UU4毒株S蛋白(GenBank:FJ938054.1))、终止密码子、polyA核酸序列进行人工合成RNA疫苗的DNA于pUC57载体上,无缝克隆于pUC57的EcoRV酶切位点,并转化大肠杆菌DH5α,获得FCoV-S-pUC57-DH5α;
本实施例所述S蛋白选用来自FCoV-I型中的UU4毒株S蛋白(GenBank:FJ938054.1),所述S蛋白还可选自FCoV-II型,也可以是所选S蛋白中的一段氨基酸序列或具有50-100%同源性的氨基酸序列,操作与上相同,在此不作重复赘述;
2.质粒的提取
将获得的重组菌进行摇菌,按照常规方法提取质粒,参照质粒抽提试剂盒(E.Z.N.A® Plasmid MiniprEppendorf Kit I)说明书进行:
2.1)取菌液于1.5mL Ep 管中12000r/min离心30s,弃上清;
2.2)加250µL溶液Ⅰ/RNase A,充分重悬菌泥;
2.3)加250µL溶液Ⅱ,颠倒4~6次混匀,室温作用2min至溶液变成澄清;
2.4)加350µL溶液Ⅲ,颠倒4~6次混匀以形成白色沉淀; 12000r/min离心10min,
2.5)转移上清至DNA吸附柱中,室温静置2min。12000r/min离心1min,弃液。
2.6)加入500 μL的Buffer HB,12000r/min离心1min,弃液。
2.7)加入750 μL的DNA Wash Buffer,12000r/min离心1min,弃液。
2.8)重复该步骤一次,再空管12000r/min离心1min。
2.9)移至新的1.5 mLEp管中,加入50~100 μL的TE室温下放置2min,12000r/min离心1min,洗脱的质粒于-20℃保存备用,取少量于1.0%琼脂糖凝胶中低压电泳检测质粒效果。
3.酶切线性化、纯化
对重组质粒进行Quick Cut MluI酶切,酶切反应体系如表1所示:
表1 酶切反应体系
Figure 793514DEST_PATH_IMAGE002
将上述成分加入0.5mL的EP管中,混匀,37℃酶切15min。纯化试剂盒进行纯化回收线性化重组质粒。
根据OMEGA公司的Cycle-pure纯化试剂盒使用说明书,线性化质粒进行纯化回收,方法如下:
3.1)将线性化质粒收集在一个1.5ml的EP管中;
3.2)加入6倍体积的Buffer CP于装有PCR产物的EP管中,小心混匀;
3.3)将上述混合液全部加至试剂盒配的有滤膜的管HiBind spin-column中,10000 r/min离心1 min,弃去离心出来的溶液;
3.4)加入700 µLSPW Buffer,等待2~3min,10 000 r/min离心1 min,弃去离心出来的溶液;
3.5)重复步骤3.4);
3.6)空管10 000 r/min离心1min;
3.8)弃去下面的离心管,将柱子放入新的干净的1.5mL离心管中,在柱子中央加入50µL DNA Elution Buffer,室温下放置2min,10 000r/min离心1min,收集离心管中的液体即为回收的DNA片段,经琼脂糖凝胶电泳检测后即用或-20℃冰箱保存备用。提高洗脱液的温度至55℃~80℃,有利于提高DNA的洗脱效率。
4.体外转录和纯化
采用体外转录试剂盒(mMESSAGE mMACHINE™ T7 ULTRA Transcription Kit)对线性化的质粒进行体外转录。
采用纯化试剂盒(MEGAclear™ Transcription Clean-Up Kit)对转录的产物进行纯化处理,即得RNA疫苗核酸;
取来自的猫源的六组5’UTR、3’UTR(选自GenBank中NCBI参考序列XM_023246781.1、XM_011290755.3、XM_003992859.2、XM_003992882.4、XM_003998693.4、X84842.1),按照以上步骤制备成六组RNA疫苗核酸,纯化之后的RNA疫苗核酸进行1%琼脂凝胶电泳鉴定,如图1所示,可见其体外转录成功。
5.纳米脂质颗粒的制备
5.1)将-80℃冰箱保存的聚合物PEG5k-b-PLGA11k,PLGA11k和BHEM-Chol取出,平衡到室温后在干燥环境下开封,分别以62.5 mg/mL,39.5mg/mL和22.5mg/mL的浓度溶于色谱级三氯甲烷溶液中;
5.2)将-80℃冰箱保存的mRNA溶液在冰上融化,使用无核酸酶水(DEPC水)调整其浓度为4 mg/mL,在50mL无菌离心管中,依次加入25 μL mRNA(0.1 mg),100 μL BHEM-Chol(2 mg),350 μL PEG5k-b-PLGA11k(21.875 mg)和50 μL PLGA11k(1.925 mg);
5.3)将该离心管置于冰水中,超声探头用DEPC水冲洗后放入离心管的溶液中,在80W功率和冰水浴条件下,以超声5s停2s的方式超声乳化溶液60 s,得到油相-水相的初乳液。随后,将5 mLDEPC水沿管壁加入到初乳液中,并在同样条件下,以超声10s停2s的方式再次乳化60 s,形成水相-油相-水相的复乳液;
5.4)将复乳液转移到DEPC处理并高压过的无菌无核酸酶100mL圆底烧瓶中,使用旋转蒸发仪在低温条件下缓慢地减压旋蒸以除去乳液中的三氯甲烷,并浓缩其水溶液体积到1mL左右,制备好的脂质纳米颗粒包裹的mRNA转移到1.5mL EP管中保存于4C冰箱中待用。
6.检测细胞转染后的FCoV-S-mRNA脂质体表达情况
6.1)取24孔板,接种猫肾细胞(CRFK)(200000个细胞/孔),采用含10%血清无抗培养基培养18小时;
6.2)当细胞贴壁融合度约达60 %时,在转染前一小时更换为无血清的Opti-MEM培养基,转染脂质纳米颗粒FCoV-S-mRNA(1μg RNA/孔),培养6小时;
6.3)将培养基替换为新鲜的培养基,培养42小时;
6.4)1000g离心10min,收集上清液;
6.5)取上清液,进行非还原型SDS-PAGE,然后进行Western blot。Western blot采用的一抗为抗E2蛋白的鼠源单克隆抗体,二抗为抗鼠源抗体。
7. FCoV-S-mRNA疫苗免疫小鼠及其抗体的测定
将6-8周龄雄性BALB/c小鼠随机分为5组(每组5只):FCoV-S-mRNA1组、FCoV-S-mRNA2组、FCoV-S-mRNA3组、FCoV-S-mRNA4组、FCoV-S-mRNA5组、FCoV-S-mRNA6组及PBS空白对照组。
采用肌内免疫,试验第1天进行初次免疫,试验第28天进行加强免疫,FCoV-S-mRNA中的各组组每次免疫剂量相同,均为20g,体积为200L,PBS空白注射组注射等体积的PBS(pH7.2,0.01M)。分别在二免14天后进行尾部采血,收集血清,用间接ELISA法测定抗体水平。
如图3所示,OD450测定结果显示FCoV-S-mRNA1组、FCoV-S-mRNA2组、FCoV-S-mRNA3组、FCoV-S-mRNA4组、FCoV-S-mRNA5组、FCoV-S-mRNA6组实验组均能够达到一定的抗体水平。
8.血清中和试验中中和效价及抗体滴度的测定
对第42d的血清进行血清中和试验,如表2所示,结果显示FCoV-S-mRNA1组、FCoV-S-mRNA2组、FCoV-S-mRNA3组、FCoV-S-mRNA4组、FCoV-S-mRNA5组、FCoV-S-mRNA6组抗体效价均显著高于PBS对照组。
表2 RNA疫苗的中和效价表
组别 中和效价
FCoV-S-mRNA1 1:320
FCoV-S-mRNA2 1:304
FCoV-S-mRNA3 1:326
FCoV-S-mRNA4 1:256
FCoV-S-mRNA5 1:304
FCoV-S-mRNA6 1:288
PBS对照 1:8
如图4所示,抗体滴度测定试验中FCoV-S-mRNA1组、FCoV-S-mRNA2组、FCoV-S-mRNA3组、FCoV-S-mRNA4组、FCoV-S-mRNA5组、FCoV-S-mRNA6组实验组中和抗体滴度均高于24,可见,本发明制备的猫冠状病毒RNA疫苗可以起到很好的保护作用,为FCoV的防控提供了有效的技术手段。
序列表
<110> 东莞博盛生物科技有限公司
<120> 一种用于猫冠状病毒的RNA疫苗及其构建方法
<160> 20
<170> SIPOSequenceListing 1.0
<210> 1
<211> 45
<212> DNA
<213> Artificial Sequence
<400> 1
gccccgcacc ttctggtccc gacacagact cagagagaac caacc 45
<210> 2
<211> 94
<212> DNA
<213> Artificial Sequence
<400> 2
gtgaagccgg ggcgatcgtc ctgagggccc ggggcctctt gggctccggg cacccgaact 60
tcctgatctt tgaataaagt ctgagtgggc tgca 94
<210> 3
<211> 57
<212> DNA
<213> Artificial Sequence
<400> 3
atcgcgtccg tgctgccatc cggcgcggag cgctcgccgc tcaacgccgg atccgcg 57
<210> 4
<211> 78
<212> DNA
<213> Artificial Sequence
<400> 4
actcggagag gggcgcccgc cgcccagccg cccctcccgc gagttccaga gtttgagtaa 60
agtccccgca agaaagcc 78
<210> 5
<211> 61
<212> DNA
<213> Artificial Sequence
<400> 5
ccaacagcag cacatacccg cttctctctc tgatcgcctg taagttccca gatctgacat 60
c 61
<210> 6
<211> 132
<212> DNA
<213> Artificial Sequence
<400> 6
gtcttccttc cagttcaacg gtgctctttt gtgtccccag ggccctcctt ctgcatatgg 60
ggacttgcgt ttggccttga gagcacagct tctgtttaat aaagttcatt ctattcagtc 120
atcataaatg aa 132
<210> 7
<211> 54
<212> DNA
<213> Artificial Sequence
<400> 7
ttacacttgc ttctgacaca actgtgttcg ctatcaacca cacaaacaga cacc 54
<210> 8
<211> 126
<212> DNA
<213> Artificial Sequence
<400> 8
gctccctttc ttgctttcca gggaaagtcc cttggtcccc agaccctaat acctggacat 60
gtctaaatca tgaaattctt tgaacatctg gctcctgcct aataaagaat atttattttc 120
attgca 126
<210> 9
<211> 118
<212> DNA
<213> Artificial Sequence
<400> 9
gggcgtttcc ctcttaggct gacacttgac tccttgtcta catttagctt agagagggac 60
atacataccc tggaaagtgt gggggagacg tacatagcac tgttggacct gaaggcag 118
<210> 10
<211> 165
<212> DNA
<213> Artificial Sequence
<400> 10
acatctgaat cacccactgc cttctctcta gcctggaaac ccaggcctac atccataaga 60
agcccttaaa tccttcctct gtgttcttca agtgctcagg ctctgacatt tcatggtgtt 120
accctaccct gacactttaa taaagactaa attggtttgc tggtc 165
<210> 11
<211> 15
<212> DNA
<213> Artificial Sequence
<400> 11
gtcgactttg gcaca 15
<210> 12
<211> 42
<212> DNA
<213> Artificial Sequence
<400> 12
aacaacacaa tcacaacatc tcagcctacc ctgagagtcg ac 42
<210> 13
<211> 1465
<212> PRT
<213> Artificial Sequence
<400> 13
Met Ile Leu Leu Ile Leu Ala Leu Leu Ser Ile Ala Ser Ser Glu Asp
1 5 10 15
Ala Pro His Gly Val Thr Leu Pro His Phe Asn Thr Ser His Asn Asn
20 25 30
Ser Lys Phe Glu Leu Asn Phe Tyr Asn Phe Leu Gln Thr Trp Asp Ile
35 40 45
Pro Pro Asn Thr Glu Thr Ile Leu Gly Gly Tyr Leu Pro Tyr Cys Asp
50 55 60
His Glu Asp Asn Cys Gly Trp Tyr Asn Phe Val Tyr Asn Asn Lys Val
65 70 75 80
Gly Pro Asn Ala Lys Tyr Ser Tyr Ile Asn Thr Gln Asn Leu Asn Ile
85 90 95
Pro Asn Val His Gly Val Tyr Phe Asp Val Arg Glu His Asn Ser Asp
100 105 110
Gly Val Trp Asp Gln Ile Asp Arg Val Gly Leu Leu Ile Ala Ile His
115 120 125
Gly Thr Ser His Tyr Ser Leu Leu Met Val Leu Gln Asp Gly Val Glu
130 135 140
Ala Ser Gln Pro His Val Ala Val Lys Ile Cys His Trp Asn Pro Gly
145 150 155 160
Asn Ile Ser Thr Tyr His Gln Phe Asp Val Asn Leu Gly Asp Gly Gly
165 170 175
Gln Cys Val Phe Asn Gln Arg Phe Ser Leu Asp Thr Val Leu Thr Ala
180 185 190
Asn Asp Phe Tyr Gly Phe Gln Trp Thr Asp Thr Tyr Val Asp Ile Tyr
195 200 205
Leu Gly Gly Thr Ile Thr Lys Val Trp Val Val Asn Asp Trp Ser Val
210 215 220
Val Glu Ala Ser Ile Ser Ser His Trp Asn Ala Leu Asn Tyr Gly Tyr
225 230 235 240
Tyr Ile Gln Phe Val Asn Arg Thr Thr Tyr Tyr Ala Tyr Asn Ser Thr
245 250 255
Gly Gly Ser Asn Tyr Thr His Leu Gln Leu Thr Glu Cys His Thr Asp
260 265 270
Tyr Cys Ala Gly Tyr Ala Lys Asn Val Phe Val Pro Ile Asp Gly Lys
275 280 285
Ile Pro Glu Gly Phe Ser Phe Ser Asn Trp Phe Leu Leu Thr Asp Lys
290 295 300
Ser Thr Leu Val Gln Gly Arg Val Leu Ser Ser Gln Pro Val Phe Val
305 310 315 320
Gln Cys Leu Arg Pro Val Pro Thr Trp Ser Asn Asn Thr Ala Val Val
325 330 335
His Phe Lys Asn Asp Val Phe Cys Pro Asn Val Thr Ala Asp Val Leu
340 345 350
Arg Phe Asn Leu Asn Phe Ser Asp Thr Asp Val Tyr Thr Asp Ser Thr
355 360 365
Thr Asp Asp Gln Leu His Phe Thr Phe Glu Asp Asn Thr Thr Ala Ser
370 375 380
Ile Thr Cys Tyr Ser Ser Ala Asn Val Thr Asp Asn Gln Pro Ala Ser
385 390 395 400
Gly Ser Ile Ser His Thr Pro Phe Val Ser Asn Ser Tyr Leu Cys Phe
405 410 415
Ala Asn Phe Ser His Ser Ser Val Ser Arg Gln Phe Leu Gly Ile Leu
420 425 430
Pro Pro Thr Val Arg Glu Phe Ala Phe Gly Arg Asp Gly Ser Ile Phe
435 440 445
Val Asn Gly Tyr Lys Tyr Phe Ser Leu Gln Pro Ile Lys Ser Val Asn
450 455 460
Phe Ser Ile Ser Ser Val Glu Asn Tyr Gly Phe Trp Thr Ile Ala Tyr
465 470 475 480
Thr Asn Tyr Thr Asp Val Met Val Asp Val Asn Gly Thr Val Ile Thr
485 490 495
Arg Leu Phe Tyr Cys Asp Ser Pro Leu Asn Arg Ile Lys Cys Gln Gln
500 505 510
Leu Lys His Glu Leu Pro Asp Gly Phe Tyr Ser Ala Ser Met Leu Val
515 520 525
Lys Lys Asp Leu Pro Lys Thr Phe Val Thr Met Pro Gln Phe Tyr Asn
530 535 540
Trp Met Asn Val Thr Leu His Val Val Leu Asn Asp Ile Glu Lys Lys
545 550 555 560
Ala Asp Ile Ile Leu Ala Gly Ala Pro Glu Leu Ala Ser Leu Ala Asp
565 570 575
Ile His Phe Glu Ile Ala Gln Ala Asn Gly Ser Val Val Asn Val Thr
580 585 590
Ser Val Cys Val Gln Ala Arg Gln Leu Ala Leu Phe Tyr Lys Tyr Thr
595 600 605
Ser Leu Gln Gly Leu Tyr Thr Tyr Ser Asn Leu Val Gln Leu Gln Asn
610 615 620
Tyr Asp Cys Pro Phe Ser Pro Gln Gln Phe Asn Asn Tyr Leu Gln Phe
625 630 635 640
Glu Thr Leu Cys Phe Asp Val Ser Pro Ala Val Ala Gly Cys Lys Trp
645 650 655
Ser Leu Val His Asp Val Lys Trp Arg Thr Gln Phe Ala Thr Ile Thr
660 665 670
Val Ser Tyr Lys Asp Gly Ala Met Ile Thr Thr Met Pro Lys Ala Gln
675 680 685
Leu Gly Phe Gln Asp Ile Ser Asn Ile Val Lys Asp Glu Cys Thr Asp
690 695 700
Tyr Asn Ile Tyr Gly Phe Gln Gly Thr Gly Ile Ile Arg Ser Thr Thr
705 710 715 720
Ser Arg Leu Val Ala Gly Leu Tyr Tyr Thr Ser Ala Ser Gly Asp Leu
725 730 735
Leu Gly Phe Lys Ile Ser Thr Thr Gly Glu Ile Phe Thr Val Val Pro
740 745 750
Cys Asp Leu Thr Ala Gln Ala Ala Val Ile Asn Asp Glu Ile Val Gly
755 760 765
Ala Ile Thr Ala Thr Asn Gln Thr Asp Leu Phe Glu Phe Val Asn His
770 775 780
Thr Trp Ser Arg Ser Ala Arg Gly Ser Ser Pro Ser Thr Val Asn Thr
785 790 795 800
Tyr Thr Met Pro Gln Phe Tyr Tyr Ile Thr Lys Trp Asn Asn Gly Thr
805 810 815
Ser Ser Asn Cys Thr Ser Val Ile Thr Tyr Ser Ser Phe Ala Ile Cys
820 825 830
Asn Thr Gly Glu Ile Lys Tyr Val Asn Val Thr His Val Glu Ile Val
835 840 845
Asp Asp Ser Val Gly Val Ile Lys Pro Val Ser Thr Gly Asn Ile Thr
850 855 860
Ile Pro Lys Asn Phe Thr Val Ala Val Gln Ala Glu Tyr Val Gln Ile
865 870 875 880
Gln Val Lys Pro Val Ala Val Asp Cys Ala Lys Tyr Val Cys Asn Gly
885 890 895
Asn Arg His Cys Leu Asn Leu Leu Thr Gln Tyr Thr Ser Ala Cys Gln
900 905 910
Thr Ile Glu Asn Ser Leu Asn Leu Gly Ala Arg Leu Glu Ser Leu Met
915 920 925
Leu Asn Asp Met Ile Thr Val Ser Asp Arg Ser Leu Glu Phe Ala Thr
930 935 940
Val Asp Lys Phe Asn Thr Thr Ala Leu Gly Gly Glu Lys Leu Gly Gly
945 950 955 960
Leu Tyr Phe Asp Gly Leu Ser Ser Leu Leu Pro Pro Arg Val Gly Met
965 970 975
Arg Ser Ala Val Glu Asp Leu Leu Phe Asn Lys Val Val Thr Ser Gly
980 985 990
Leu Gly Thr Val Asp Asp Asp Tyr Lys Lys Cys Ser Ala Gly Thr Asp
995 1000 1005
Val Ala Asp Leu Val Cys Ala Gln Tyr Tyr Asn Gly Ile Met Val Leu
1010 1015 1020
Pro Gly Val Val Asp Tyr Asn Lys Met Ala Met Tyr Thr Ala Ser Leu
1025 1030 1035 1040
Ile Gly Gly Met Ala Leu Gly Ser Ile Thr Ser Ala Val Ala Val Pro
1045 1050 1055
Phe Ser Met Gln Val Gln Ala Arg Leu Asn Tyr Val Ala Leu Gln Thr
1060 1065 1070
Asp Val Leu Gln Glu Asn Gln Lys Ile Leu Ala Asn Ala Phe Asn Asn
1075 1080 1085
Ala Ile Gly Asn Ile Thr Leu Ala Leu Gly Lys Val Ser Asn Ala Ile
1090 1095 1100
Thr Thr Val Ser Asp Gly Phe Asn Ser Met Ala Ser Ala Leu Thr Lys
1105 1110 1115 1120
Ile Gln Ser Val Val Asn Gln Gln Gly Glu Ala Leu Ser His Leu Ile
1125 1130 1135
Ser Gln Leu Gln Lys Asn Phe Gln Ala Ile Ser Ser Ser Ile Ala Glu
1140 1145 1150
Ile Tyr Asn Arg Leu Glu Lys Val Glu Ala Asp Ala Gln Val Asp Arg
1155 1160 1165
Leu Ile Thr Gly Arg Leu Ala Ala Leu Asn Ala Tyr Val Ala Gln Thr
1170 1175 1180
Leu Thr Gln Tyr Ala Glu Val Lys Ala Ser Arg Gln Leu Ala Met Glu
1185 1190 1195 1200
Lys Val Asn Glu Cys Val Lys Ser Gln Ser Asp Arg Tyr Gly Phe Cys
1205 1210 1215
Gly Asn Gly Thr His Leu Phe Ser Leu Val Asn Ser Ala Pro Asp Gly
1220 1225 1230
Leu Leu Phe Phe His Thr Val Leu Leu Pro Thr Glu Trp Glu Glu Val
1235 1240 1245
Thr Ala Trp Ser Gly Ile Cys Val Asn Asp Thr Tyr Ala Tyr Leu Leu
1250 1255 1260
Lys Asp Phe Asp His Ser Ile Phe Ser Tyr Asn Gly Thr Tyr Met Val
1265 1270 1275 1280
Thr Pro Arg Asn Met Phe Gln Pro Arg Lys Pro Gln Met Ser Asp Phe
1285 1290 1295
Val Gln Ile Thr Ser Cys Glu Val Thr Phe Leu Asn Thr Thr His Thr
1300 1305 1310
Thr Phe Gln Glu Ile Val Ile Asp Tyr Ile Asp Ile Asn Lys Thr Ile
1315 1320 1325
Ala Asp Met Leu Glu Gln Tyr His Ser Asn Tyr Thr Thr Pro Glu Leu
1330 1335 1340
Asp Leu Gln Leu Glu Ile Phe Asn Gln Thr Lys Leu Asn Leu Thr Ala
1345 1350 1355 1360
Glu Ile Asp Gln Leu Glu Gln Arg Ala Asp Asn Leu Thr Asn Ile Ala
1365 1370 1375
His Glu Leu Gln Gln Tyr Ile Asp Asn Leu Asn Lys Thr Ile Val Asp
1380 1385 1390
Leu Glu Trp Leu Asn Arg Ile Glu Thr Tyr Val Lys Trp Pro Trp Tyr
1395 1400 1405
Val Trp Leu Leu Ile Gly Leu Val Val Val Phe Cys Ile Pro Leu Leu
1410 1415 1420
Leu Phe Cys Cys Leu Ser Thr Gly Cys Cys Gly Cys Phe Gly Cys Leu
1425 1430 1435 1440
Gly Ser Cys Cys His Ser Leu Cys Ser Arg Arg Gln Phe Glu Ser Tyr
1445 1450 1455
Glu Pro Ile Glu Lys Val His Val His
1460 1465
<210> 14
<211> 4395
<212> DNA
<213> Artificial Sequence
<400> 14
atgatcttgt taatacttgc actccttagc attgctagct ctgaagatgc tcctcatggt 60
gtcaccttgc cccacttcaa cacgtcccat aacaattcca agtttgaact taacttttac 120
aatttcttac agacttggga cataccaccg aatacagaaa ctattctggg tggttactta 180
ccatattgtg accatgaaga caattgtgga tggtataatt ttgtttataa caacaaagtg 240
ggaccaaatg ctaagtattc ctacataaac acccaaaact tgaacatacc aaatgtccat 300
ggtgtgtact ttgatgtacg agaacacaat tctgatggtg tgtgggatca aattgacaga 360
gttggcttat tgatagccat tcatggcact tcgcattata gtctacttat ggttttacag 420
gatggcgtgg aggcgagtca gcctcatgtt gctgttaaaa tttgccattg gaatccaggt 480
aacataagta cttaccatca atttgatgta aatctaggag atggtggtca atgcgttttt 540
aatcaaagat tctcattgga caccgtgttg accgctaatg acttctatgg cttccaatgg 600
actgacacat atgtagacat atacttaggt ggcactatta ctaaagtatg ggttgtaaat 660
gattggagtg ttgttgaagc tagcatttca tctcattgga atgcacttaa ttatggttac 720
tacattcaat ttgtcaatcg caccacttat tacgcttaca atagtactgg tggttcaaat 780
tatacccatc tgcagttaac tgagtgccat actgactact gtgctggtta tgctaagaat 840
gtctttgtgc caattgatgg caaaatacca gaaggctttt cttttagcaa ttggtttctt 900
ttaacagata aatccactct agtgcaagga cgtgttctta gtagtcagcc tgtttttgta 960
caatgcctta gacctgtacc aacatggtct aacaatactg ctgtggtgca ttttaaaaat 1020
gatgttttct gccctaacgt cacggcagac gttttgaggt tcaatctaaa ttttagtgac 1080
actgatgttt atacagattc aacaactgat gatcagttgc attttacatt tgaagataat 1140
acaactgcat ccataacctg ttacagcagt gctaatgtca ctgacaacca acctgcaagt 1200
ggcagcatct cacatactcc ctttgtcagc aactcttacc tctgttttgc caatttttct 1260
cactctagtg tgagcagaca gttcttaggt atactaccac caactgtacg agagtttgca 1320
ttcggcagag atggatccat ttttgttaat ggctataaat attttagttt acaacctatt 1380
aagagtgtta acttctccat cagttcagtg gagaattatg gcttttggac catagcctat 1440
actaactata cagatgtaat ggtggatgtt aatggcacag ttattactag gttattctat 1500
tgtgactcac ccctcaatag aattaagtgt caacaattga agcatgagct accagatggg 1560
ttttattcag ctagcatgct tgttaaaaag gatctaccta agacttttgt aactatgcca 1620
cagttctaca attggatgaa tgttacgcta catgtcgttt taaatgacat tgaaaaaaaa 1680
gctgacatca tcttggctgg ggctccagaa ttagcttcac ttgccgacat acactttgaa 1740
atagcacagg ctaatgggag tgtagtgaat gtcactagtg tgtgtgttca ggcaagacag 1800
ttggctttat tctacaagta cactagccta caaggtttgt acacttattc taatctggtg 1860
cagttacaaa attatgactg tcccttctcg ccacagcagt ttaataatta tttgcagttt 1920
gaaactctgt gttttgatgt aagcccagct gttgcaggtt gtaagtggtc gttagttcat 1980
gacgttaaat ggcgcacaca gtttgcaaca attactgtgt cttacaaaga tggtgcaatg 2040
attactacta tgccaaaggc acagctgggt tttcaggaca tctccaatat tgttaaagat 2100
gaatgtacag attataatat atatggcttt caaggcacag gcattattag aagtaccaca 2160
tcaagattgg tcgctggtct ttactacacc tcagctagtg gtgacctcct cggatttaaa 2220
attagcacta caggtgaaat tttcaccgtg gtgccatgtg acttaacagc tcaagcagca 2280
gtgattaatg acgaaatagt gggagctata acagccacta atcaaactga tctgtttgag 2340
tttgtaaatc acacatggtc gagaagtgca cgcgggtcat caccaagcac agttaacacc 2400
tacactatgc cccaatttta ttacataaca aagtggaata atggcacatc ttctaattgc 2460
acatctgtca ttacctactc ctcttttgca atctgtaata ctggtgaaat taaatatgtt 2520
aatgttaccc atgttgaaat tgtggatgac agtgtaggtg ttattaaacc tgtttcaaca 2580
ggtaatataa ctatacctaa aaatttcaca gttgcagtgc aagctgaata tgttcagatt 2640
caagtcaaac ctgttgctgt tgattgtgct aagtacgttt gcaatggaaa tagacattgc 2700
cttaacttgc taacacaata cacctcggct tgtcaaacaa tagaaaattc ccttaacctt 2760
ggtgcacgcc ttgaatcgtt aatgcttaat gacatgatca cagtgtcaga tcgtagtcta 2820
gaattcgcaa ctgttgataa gtttaatact acagctttag gtggtgaaaa actgggtggt 2880
ttatactttg atggtctgag tagcctatta ccacccagag taggtatgag gtctgctgtt 2940
gaagatctat tgttcaataa agtggtaact agtggtcttg gcactgtgga tgatgattat 3000
aaaaagtgtt cagctggtac agatgtagct gacctagttt gtgcccaata ttacaacggc 3060
ataatggtct tacctggcgt cgtagattat aataagatgg ccatgtatac tgcatcttta 3120
ataggaggta tggctttggg ttctattact tcagctgtcg ccgtgccttt ttctatgcaa 3180
gtacaggcca gacttaacta tgtcgcgtta caaactgatg tcctacagga aaaccagaaa 3240
atacttgcta atgcttttaa taatgccatt ggcaacatta cactagctct tggaaaagtt 3300
tccaatgcta ttacaaccgt ctcagatgga tttaatagta tggcctcagc actgactaag 3360
attcagagtg tagttaacca acagggtgaa gcgttgagtc atctcatcag tcagttacag 3420
aaaaacttcc aggctattag tagttccatt gctgaaatct acaatagatt ggaaaaagtg 3480
gaagctgatg ctcaagttga ccgactcatt actggaagat tggcagcact taatgcctat 3540
gtggctcaaa ctttaactca gtatgctgaa gtcaaggcta gtagacagtt ggcaatggag 3600
aaagttaatg agtgtgtgaa atcacagtcg gataggtatg ggttctgtgg aaatggaacg 3660
cacctattct cactcgtcaa ttccgcacct gatggtttgc ttttctttca cacagtcttg 3720
cttcctacag aatgggaaga agtgacggca tggtcaggaa tatgtgttaa tgacacttat 3780
gcatatctgt tgaaagattt cgatcattcc attttcagct acaatggcac gtatatggta 3840
actcctcgta acatgtttca acctagaaaa cctcagatga gtgatttcgt gcaaattacg 3900
agttgtgaag tgacatttct gaacactaca catacgacat ttcaggagat tgtgattgat 3960
tatattgaca tcaacaagac tatcgctgat atgcttgaac aataccattc taattacaca 4020
acacctgagt tagacttaca gctggaaatt tttaatcaga caaagttaaa cctcactgca 4080
gaaatagacc aattggaaca aagagcagac aacctcacta atatcgcaca tgaactacag 4140
cagtacattg acaaccttaa taagactatt gttgacctcg aatggctcaa caggattgaa 4200
acttatgtaa aatggccatg gtatgtgtgg ctactaattg gattagtagt agtcttctgc 4260
ataccattgt tactgttttg ctgtcttagc acaggctgct gtgggtgttt tggttgtctt 4320
ggaagttgtt gtcattctct ttgcagtaga cgtcaatttg aaagttatga acctattgaa 4380
aaggttcacg ttcat 4395
<210> 15
<211> 4613
<212> DNA
<213> Artificial Sequence
<400> 15
gccccgcacc ttctggtccc gacacagact cagagagaac caaccatgat cttgttaata 60
cttgcactcc ttagcattgc tagctctgaa gatgctcctc atggtgtcac cttgccccac 120
ttcaacacgt cccataacaa ttccaagttt gaacttaact tttacaattt cttacagact 180
tgggacatac caccgaatac agaaactatt ctgggtggtt acttaccata ttgtgaccat 240
gaagacaatt gtggatggta taattttgtt tataacaaca aagtgggacc aaatgctaag 300
tattcctaca taaacaccca aaacttgaac ataccaaatg tccatggtgt gtactttgat 360
gtacgagaac acaattctga tggtgtgtgg gatcaaattg acagagttgg cttattgata 420
gccattcatg gcacttcgca ttatagtcta cttatggttt tacaggatgg cgtggaggcg 480
agtcagcctc atgttgctgt taaaatttgc cattggaatc caggtaacat aagtacttac 540
catcaatttg atgtaaatct aggagatggt ggtcaatgcg tttttaatca aagattctca 600
ttggacaccg tgttgaccgc taatgacttc tatggcttcc aatggactga cacatatgta 660
gacatatact taggtggcac tattactaaa gtatgggttg taaatgattg gagtgttgtt 720
gaagctagca tttcatctca ttggaatgca cttaattatg gttactacat tcaatttgtc 780
aatcgcacca cttattacgc ttacaatagt actggtggtt caaattatac ccatctgcag 840
ttaactgagt gccatactga ctactgtgct ggttatgcta agaatgtctt tgtgccaatt 900
gatggcaaaa taccagaagg cttttctttt agcaattggt ttcttttaac agataaatcc 960
actctagtgc aaggacgtgt tcttagtagt cagcctgttt ttgtacaatg ccttagacct 1020
gtaccaacat ggtctaacaa tactgctgtg gtgcatttta aaaatgatgt tttctgccct 1080
aacgtcacgg cagacgtttt gaggttcaat ctaaatttta gtgacactga tgtttataca 1140
gattcaacaa ctgatgatca gttgcatttt acatttgaag ataatacaac tgcatccata 1200
acctgttaca gcagtgctaa tgtcactgac aaccaacctg caagtggcag catctcacat 1260
actccctttg tcagcaactc ttacctctgt tttgccaatt tttctcactc tagtgtgagc 1320
agacagttct taggtatact accaccaact gtacgagagt ttgcattcgg cagagatgga 1380
tccatttttg ttaatggcta taaatatttt agtttacaac ctattaagag tgttaacttc 1440
tccatcagtt cagtggagaa ttatggcttt tggaccatag cctatactaa ctatacagat 1500
gtaatggtgg atgttaatgg cacagttatt actaggttat tctattgtga ctcacccctc 1560
aatagaatta agtgtcaaca attgaagcat gagctaccag atgggtttta ttcagctagc 1620
atgcttgtta aaaaggatct acctaagact tttgtaacta tgccacagtt ctacaattgg 1680
atgaatgtta cgctacatgt cgttttaaat gacattgaaa aaaaagctga catcatcttg 1740
gctggggctc cagaattagc ttcacttgcc gacatacact ttgaaatagc acaggctaat 1800
gggagtgtag tgaatgtcac tagtgtgtgt gttcaggcaa gacagttggc tttattctac 1860
aagtacacta gcctacaagg tttgtacact tattctaatc tggtgcagtt acaaaattat 1920
gactgtccct tctcgccaca gcagtttaat aattatttgc agtttgaaac tctgtgtttt 1980
gatgtaagcc cagctgttgc aggttgtaag tggtcgttag ttcatgacgt taaatggcgc 2040
acacagtttg caacaattac tgtgtcttac aaagatggtg caatgattac tactatgcca 2100
aaggcacagc tgggttttca ggacatctcc aatattgtta aagatgaatg tacagattat 2160
aatatatatg gctttcaagg cacaggcatt attagaagta ccacatcaag attggtcgct 2220
ggtctttact acacctcagc tagtggtgac ctcctcggat ttaaaattag cactacaggt 2280
gaaattttca ccgtggtgcc atgtgactta acagctcaag cagcagtgat taatgacgaa 2340
atagtgggag ctataacagc cactaatcaa actgatctgt ttgagtttgt aaatcacaca 2400
tggtcgagaa gtgcacgcgg gtcatcacca agcacagtta acacctacac tatgccccaa 2460
ttttattaca taacaaagtg gaataatggc acatcttcta attgcacatc tgtcattacc 2520
tactcctctt ttgcaatctg taatactggt gaaattaaat atgttaatgt tacccatgtt 2580
gaaattgtgg atgacagtgt aggtgttatt aaacctgttt caacaggtaa tataactata 2640
cctaaaaatt tcacagttgc agtgcaagct gaatatgttc agattcaagt caaacctgtt 2700
gctgttgatt gtgctaagta cgtttgcaat ggaaatagac attgccttaa cttgctaaca 2760
caatacacct cggcttgtca aacaatagaa aattccctta accttggtgc acgccttgaa 2820
tcgttaatgc ttaatgacat gatcacagtg tcagatcgta gtctagaatt cgcaactgtt 2880
gataagttta atactacagc tttaggtggt gaaaaactgg gtggtttata ctttgatggt 2940
ctgagtagcc tattaccacc cagagtaggt atgaggtctg ctgttgaaga tctattgttc 3000
aataaagtgg taactagtgg tcttggcact gtggatgatg attataaaaa gtgttcagct 3060
ggtacagatg tagctgacct agtttgtgcc caatattaca acggcataat ggtcttacct 3120
ggcgtcgtag attataataa gatggccatg tatactgcat ctttaatagg aggtatggct 3180
ttgggttcta ttacttcagc tgtcgccgtg cctttttcta tgcaagtaca ggccagactt 3240
aactatgtcg cgttacaaac tgatgtccta caggaaaacc agaaaatact tgctaatgct 3300
tttaataatg ccattggcaa cattacacta gctcttggaa aagtttccaa tgctattaca 3360
accgtctcag atggatttaa tagtatggcc tcagcactga ctaagattca gagtgtagtt 3420
aaccaacagg gtgaagcgtt gagtcatctc atcagtcagt tacagaaaaa cttccaggct 3480
attagtagtt ccattgctga aatctacaat agattggaaa aagtggaagc tgatgctcaa 3540
gttgaccgac tcattactgg aagattggca gcacttaatg cctatgtggc tcaaacttta 3600
actcagtatg ctgaagtcaa ggctagtaga cagttggcaa tggagaaagt taatgagtgt 3660
gtgaaatcac agtcggatag gtatgggttc tgtggaaatg gaacgcacct attctcactc 3720
gtcaattccg cacctgatgg tttgcttttc tttcacacag tcttgcttcc tacagaatgg 3780
gaagaagtga cggcatggtc aggaatatgt gttaatgaca cttatgcata tctgttgaaa 3840
gatttcgatc attccatttt cagctacaat ggcacgtata tggtaactcc tcgtaacatg 3900
tttcaaccta gaaaacctca gatgagtgat ttcgtgcaaa ttacgagttg tgaagtgaca 3960
tttctgaaca ctacacatac gacatttcag gagattgtga ttgattatat tgacatcaac 4020
aagactatcg ctgatatgct tgaacaatac cattctaatt acacaacacc tgagttagac 4080
ttacagctgg aaatttttaa tcagacaaag ttaaacctca ctgcagaaat agaccaattg 4140
gaacaaagag cagacaacct cactaatatc gcacatgaac tacagcagta cattgacaac 4200
cttaataaga ctattgttga cctcgaatgg ctcaacagga ttgaaactta tgtaaaatgg 4260
ccatggtatg tgtggctact aattggatta gtagtagtct tctgcatacc attgttactg 4320
ttttgctgtc ttagcacagg ctgctgtggg tgttttggtt gtcttggaag ttgttgtcat 4380
tctctttgca gtagacgtca atttgaaagt tatgaaccta ttgaaaaggt tcacgttcat 4440
tgataataag tgaagccggg gcgatcgtcc tgagggcccg gggcctcttg ggctccgggc 4500
acccgaactt cctgatcttt gaataaagtc tgagtgggct gcaaaaaaaa aaaaaaaaaa 4560
aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaa 4613
<210> 16
<211> 4609
<212> DNA
<213> Artificial Sequence
<400> 16
atcgcgtccg tgctgccatc cggcgcggag cgctcgccgc tcaacgccgg atccgcgatg 60
atcttgttaa tacttgcact ccttagcatt gctagctctg aagatgctcc tcatggtgtc 120
accttgcccc acttcaacac gtcccataac aattccaagt ttgaacttaa cttttacaat 180
ttcttacaga cttgggacat accaccgaat acagaaacta ttctgggtgg ttacttacca 240
tattgtgacc atgaagacaa ttgtggatgg tataattttg tttataacaa caaagtggga 300
ccaaatgcta agtattccta cataaacacc caaaacttga acataccaaa tgtccatggt 360
gtgtactttg atgtacgaga acacaattct gatggtgtgt gggatcaaat tgacagagtt 420
ggcttattga tagccattca tggcacttcg cattatagtc tacttatggt tttacaggat 480
ggcgtggagg cgagtcagcc tcatgttgct gttaaaattt gccattggaa tccaggtaac 540
ataagtactt accatcaatt tgatgtaaat ctaggagatg gtggtcaatg cgtttttaat 600
caaagattct cattggacac cgtgttgacc gctaatgact tctatggctt ccaatggact 660
gacacatatg tagacatata cttaggtggc actattacta aagtatgggt tgtaaatgat 720
tggagtgttg ttgaagctag catttcatct cattggaatg cacttaatta tggttactac 780
attcaatttg tcaatcgcac cacttattac gcttacaata gtactggtgg ttcaaattat 840
acccatctgc agttaactga gtgccatact gactactgtg ctggttatgc taagaatgtc 900
tttgtgccaa ttgatggcaa aataccagaa ggcttttctt ttagcaattg gtttctttta 960
acagataaat ccactctagt gcaaggacgt gttcttagta gtcagcctgt ttttgtacaa 1020
tgccttagac ctgtaccaac atggtctaac aatactgctg tggtgcattt taaaaatgat 1080
gttttctgcc ctaacgtcac ggcagacgtt ttgaggttca atctaaattt tagtgacact 1140
gatgtttata cagattcaac aactgatgat cagttgcatt ttacatttga agataataca 1200
actgcatcca taacctgtta cagcagtgct aatgtcactg acaaccaacc tgcaagtggc 1260
agcatctcac atactccctt tgtcagcaac tcttacctct gttttgccaa tttttctcac 1320
tctagtgtga gcagacagtt cttaggtata ctaccaccaa ctgtacgaga gtttgcattc 1380
ggcagagatg gatccatttt tgttaatggc tataaatatt ttagtttaca acctattaag 1440
agtgttaact tctccatcag ttcagtggag aattatggct tttggaccat agcctatact 1500
aactatacag atgtaatggt ggatgttaat ggcacagtta ttactaggtt attctattgt 1560
gactcacccc tcaatagaat taagtgtcaa caattgaagc atgagctacc agatgggttt 1620
tattcagcta gcatgcttgt taaaaaggat ctacctaaga cttttgtaac tatgccacag 1680
ttctacaatt ggatgaatgt tacgctacat gtcgttttaa atgacattga aaaaaaagct 1740
gacatcatct tggctggggc tccagaatta gcttcacttg ccgacataca ctttgaaata 1800
gcacaggcta atgggagtgt agtgaatgtc actagtgtgt gtgttcaggc aagacagttg 1860
gctttattct acaagtacac tagcctacaa ggtttgtaca cttattctaa tctggtgcag 1920
ttacaaaatt atgactgtcc cttctcgcca cagcagttta ataattattt gcagtttgaa 1980
actctgtgtt ttgatgtaag cccagctgtt gcaggttgta agtggtcgtt agttcatgac 2040
gttaaatggc gcacacagtt tgcaacaatt actgtgtctt acaaagatgg tgcaatgatt 2100
actactatgc caaaggcaca gctgggtttt caggacatct ccaatattgt taaagatgaa 2160
tgtacagatt ataatatata tggctttcaa ggcacaggca ttattagaag taccacatca 2220
agattggtcg ctggtcttta ctacacctca gctagtggtg acctcctcgg atttaaaatt 2280
agcactacag gtgaaatttt caccgtggtg ccatgtgact taacagctca agcagcagtg 2340
attaatgacg aaatagtggg agctataaca gccactaatc aaactgatct gtttgagttt 2400
gtaaatcaca catggtcgag aagtgcacgc gggtcatcac caagcacagt taacacctac 2460
actatgcccc aattttatta cataacaaag tggaataatg gcacatcttc taattgcaca 2520
tctgtcatta cctactcctc ttttgcaatc tgtaatactg gtgaaattaa atatgttaat 2580
gttacccatg ttgaaattgt ggatgacagt gtaggtgtta ttaaacctgt ttcaacaggt 2640
aatataacta tacctaaaaa tttcacagtt gcagtgcaag ctgaatatgt tcagattcaa 2700
gtcaaacctg ttgctgttga ttgtgctaag tacgtttgca atggaaatag acattgcctt 2760
aacttgctaa cacaatacac ctcggcttgt caaacaatag aaaattccct taaccttggt 2820
gcacgccttg aatcgttaat gcttaatgac atgatcacag tgtcagatcg tagtctagaa 2880
ttcgcaactg ttgataagtt taatactaca gctttaggtg gtgaaaaact gggtggttta 2940
tactttgatg gtctgagtag cctattacca cccagagtag gtatgaggtc tgctgttgaa 3000
gatctattgt tcaataaagt ggtaactagt ggtcttggca ctgtggatga tgattataaa 3060
aagtgttcag ctggtacaga tgtagctgac ctagtttgtg cccaatatta caacggcata 3120
atggtcttac ctggcgtcgt agattataat aagatggcca tgtatactgc atctttaata 3180
ggaggtatgg ctttgggttc tattacttca gctgtcgccg tgcctttttc tatgcaagta 3240
caggccagac ttaactatgt cgcgttacaa actgatgtcc tacaggaaaa ccagaaaata 3300
cttgctaatg cttttaataa tgccattggc aacattacac tagctcttgg aaaagtttcc 3360
aatgctatta caaccgtctc agatggattt aatagtatgg cctcagcact gactaagatt 3420
cagagtgtag ttaaccaaca gggtgaagcg ttgagtcatc tcatcagtca gttacagaaa 3480
aacttccagg ctattagtag ttccattgct gaaatctaca atagattgga aaaagtggaa 3540
gctgatgctc aagttgaccg actcattact ggaagattgg cagcacttaa tgcctatgtg 3600
gctcaaactt taactcagta tgctgaagtc aaggctagta gacagttggc aatggagaaa 3660
gttaatgagt gtgtgaaatc acagtcggat aggtatgggt tctgtggaaa tggaacgcac 3720
ctattctcac tcgtcaattc cgcacctgat ggtttgcttt tctttcacac agtcttgctt 3780
cctacagaat gggaagaagt gacggcatgg tcaggaatat gtgttaatga cacttatgca 3840
tatctgttga aagatttcga tcattccatt ttcagctaca atggcacgta tatggtaact 3900
cctcgtaaca tgtttcaacc tagaaaacct cagatgagtg atttcgtgca aattacgagt 3960
tgtgaagtga catttctgaa cactacacat acgacatttc aggagattgt gattgattat 4020
attgacatca acaagactat cgctgatatg cttgaacaat accattctaa ttacacaaca 4080
cctgagttag acttacagct ggaaattttt aatcagacaa agttaaacct cactgcagaa 4140
atagaccaat tggaacaaag agcagacaac ctcactaata tcgcacatga actacagcag 4200
tacattgaca accttaataa gactattgtt gacctcgaat ggctcaacag gattgaaact 4260
tatgtaaaat ggccatggta tgtgtggcta ctaattggat tagtagtagt cttctgcata 4320
ccattgttac tgttttgctg tcttagcaca ggctgctgtg ggtgttttgg ttgtcttgga 4380
agttgttgtc attctctttg cagtagacgt caatttgaaa gttatgaacc tattgaaaag 4440
gttcacgttc attgataata aactcggaga ggggcgcccg ccgcccagcc gcccctcccg 4500
cgagttccag agtttgagta aagtccccgc aagaaagcca aaaaaaaaaa aaaaaaaaaa 4560
aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaa 4609
<210> 17
<211> 4664
<212> DNA
<213> Artificial Sequence
<400> 17
ccaacagcag cacatacccg cttctctctc tgatcgcctg taagttccca gatctgacat 60
catgatcttg ttaatacttg cactccttag cattgctagc tctgaagatg ctcctcatgg 120
tgtcaccttg ccccacttca acacgtccca taacaattcc aagtttgaac ttaactttta 180
caatttctta cagacttggg acataccacc gaatacagaa actattctgg gtggttactt 240
accatattgt gaccatgaag acaattgtgg atggtataat tttgtttata acaacaaagt 300
gggaccaaat gctaagtatt cctacataaa cacccaaaac ttgaacatac caaatgtcca 360
tggtgtgtac tttgatgtac gagaacacaa ttctgatggt gtgtgggatc aaattgacag 420
agttggctta ttgatagcca ttcatggcac ttcgcattat agtctactta tggttttaca 480
ggatggcgtg gaggcgagtc agcctcatgt tgctgttaaa atttgccatt ggaatccagg 540
taacataagt acttaccatc aatttgatgt aaatctagga gatggtggtc aatgcgtttt 600
taatcaaaga ttctcattgg acaccgtgtt gaccgctaat gacttctatg gcttccaatg 660
gactgacaca tatgtagaca tatacttagg tggcactatt actaaagtat gggttgtaaa 720
tgattggagt gttgttgaag ctagcatttc atctcattgg aatgcactta attatggtta 780
ctacattcaa tttgtcaatc gcaccactta ttacgcttac aatagtactg gtggttcaaa 840
ttatacccat ctgcagttaa ctgagtgcca tactgactac tgtgctggtt atgctaagaa 900
tgtctttgtg ccaattgatg gcaaaatacc agaaggcttt tcttttagca attggtttct 960
tttaacagat aaatccactc tagtgcaagg acgtgttctt agtagtcagc ctgtttttgt 1020
acaatgcctt agacctgtac caacatggtc taacaatact gctgtggtgc attttaaaaa 1080
tgatgttttc tgccctaacg tcacggcaga cgttttgagg ttcaatctaa attttagtga 1140
cactgatgtt tatacagatt caacaactga tgatcagttg cattttacat ttgaagataa 1200
tacaactgca tccataacct gttacagcag tgctaatgtc actgacaacc aacctgcaag 1260
tggcagcatc tcacatactc cctttgtcag caactcttac ctctgttttg ccaatttttc 1320
tcactctagt gtgagcagac agttcttagg tatactacca ccaactgtac gagagtttgc 1380
attcggcaga gatggatcca tttttgttaa tggctataaa tattttagtt tacaacctat 1440
taagagtgtt aacttctcca tcagttcagt ggagaattat ggcttttgga ccatagccta 1500
tactaactat acagatgtaa tggtggatgt taatggcaca gttattacta ggttattcta 1560
ttgtgactca cccctcaata gaattaagtg tcaacaattg aagcatgagc taccagatgg 1620
gttttattca gctagcatgc ttgttaaaaa ggatctacct aagacttttg taactatgcc 1680
acagttctac aattggatga atgttacgct acatgtcgtt ttaaatgaca ttgaaaaaaa 1740
agctgacatc atcttggctg gggctccaga attagcttca cttgccgaca tacactttga 1800
aatagcacag gctaatggga gtgtagtgaa tgtcactagt gtgtgtgttc aggcaagaca 1860
gttggcttta ttctacaagt acactagcct acaaggtttg tacacttatt ctaatctggt 1920
gcagttacaa aattatgact gtcccttctc gccacagcag tttaataatt atttgcagtt 1980
tgaaactctg tgttttgatg taagcccagc tgttgcaggt tgtaagtggt cgttagttca 2040
tgacgttaaa tggcgcacac agtttgcaac aattactgtg tcttacaaag atggtgcaat 2100
gattactact atgccaaagg cacagctggg ttttcaggac atctccaata ttgttaaaga 2160
tgaatgtaca gattataata tatatggctt tcaaggcaca ggcattatta gaagtaccac 2220
atcaagattg gtcgctggtc tttactacac ctcagctagt ggtgacctcc tcggatttaa 2280
aattagcact acaggtgaaa ttttcaccgt ggtgccatgt gacttaacag ctcaagcagc 2340
agtgattaat gacgaaatag tgggagctat aacagccact aatcaaactg atctgtttga 2400
gtttgtaaat cacacatggt cgagaagtgc acgcgggtca tcaccaagca cagttaacac 2460
ctacactatg ccccaatttt attacataac aaagtggaat aatggcacat cttctaattg 2520
cacatctgtc attacctact cctcttttgc aatctgtaat actggtgaaa ttaaatatgt 2580
taatgttacc catgttgaaa ttgtggatga cagtgtaggt gttattaaac ctgtttcaac 2640
aggtaatata actataccta aaaatttcac agttgcagtg caagctgaat atgttcagat 2700
tcaagtcaaa cctgttgctg ttgattgtgc taagtacgtt tgcaatggaa atagacattg 2760
ccttaacttg ctaacacaat acacctcggc ttgtcaaaca atagaaaatt cccttaacct 2820
tggtgcacgc cttgaatcgt taatgcttaa tgacatgatc acagtgtcag atcgtagtct 2880
agaattcgca actgttgata agtttaatac tacagcttta ggtggtgaaa aactgggtgg 2940
tttatacttt gatggtctga gtagcctatt accacccaga gtaggtatga ggtctgctgt 3000
tgaagatcta ttgttcaata aagtggtaac tagtggtctt ggcactgtgg atgatgatta 3060
taaaaagtgt tcagctggta cagatgtagc tgacctagtt tgtgcccaat attacaacgg 3120
cataatggtc ttacctggcg tcgtagatta taataagatg gccatgtata ctgcatcttt 3180
aataggaggt atggctttgg gttctattac ttcagctgtc gccgtgcctt tttctatgca 3240
agtacaggcc agacttaact atgtcgcgtt acaaactgat gtcctacagg aaaaccagaa 3300
aatacttgct aatgctttta ataatgccat tggcaacatt acactagctc ttggaaaagt 3360
ttccaatgct attacaaccg tctcagatgg atttaatagt atggcctcag cactgactaa 3420
gattcagagt gtagttaacc aacagggtga agcgttgagt catctcatca gtcagttaca 3480
gaaaaacttc caggctatta gtagttccat tgctgaaatc tacaatagat tggaaaaagt 3540
ggaagctgat gctcaagttg accgactcat tactggaaga ttggcagcac ttaatgccta 3600
tgtggctcaa actttaactc agtatgctga agtcaaggct agtagacagt tggcaatgga 3660
gaaagttaat gagtgtgtga aatcacagtc ggataggtat gggttctgtg gaaatggaac 3720
gcacctattc tcactcgtca attccgcacc tgatggtttg cttttctttc acacagtctt 3780
gcttcctaca gaatgggaag aagtgacggc atggtcagga atatgtgtta atgacactta 3840
tgcatatctg ttgaaagatt tcgatcattc cattttcagc tacaatggca cgtatatggt 3900
aactcctcgt aacatgtttc aacctagaaa acctcagatg agtgatttcg tgcaaattac 3960
gagttgtgaa gtgacatttc tgaacactac acatacgaca tttcaggaga ttgtgattga 4020
ttatattgac atcaacaaga ctatcgctga tatgcttgaa caataccatt ctaattacac 4080
aacacctgag ttagacttac agctggaaat ttttaatcag acaaagttaa acctcactgc 4140
agaaatagac caattggaac aaagagcaga caacctcact aatatcgcac atgaactaca 4200
gcagtacatt gacaacctta ataagactat tgttgacctc gaatggctca acaggattga 4260
aacttatgta aaatggccat ggtatgtgtg gctactaatt ggattagtag tagtcttctg 4320
cataccattg ttactgtttt gctgtcttag cacaggctgc tgtgggtgtt ttggttgtct 4380
tggaagttgt tgtcattctc tttgcagtag acgtcaattt gaaagttatg aacctattga 4440
aaaggttcac gttcattgat gagtcttcct tccagttcaa cggtgctctt ttgtgtcccc 4500
agggccctcc ttctgcatat ggggacttgc gtttggcctt gagagcacag cttctgttta 4560
ataaagttca ttctattcag tcatcataaa tgaaaaaaaa aaaaaaaaaa aaaaaaaaaa 4620
aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaa 4664
<210> 18
<211> 4651
<212> DNA
<213> Artificial Sequence
<400> 18
ttacacttgc ttctgacaca actgtgttcg ctatcaacca cacaaacaga caccatgatc 60
ttgttaatac ttgcactcct tagcattgct agctctgaag atgctcctca tggtgtcacc 120
ttgccccact tcaacacgtc ccataacaat tccaagtttg aacttaactt ttacaatttc 180
ttacagactt gggacatacc accgaataca gaaactattc tgggtggtta cttaccatat 240
tgtgaccatg aagacaattg tggatggtat aattttgttt ataacaacaa agtgggacca 300
aatgctaagt attcctacat aaacacccaa aacttgaaca taccaaatgt ccatggtgtg 360
tactttgatg tacgagaaca caattctgat ggtgtgtggg atcaaattga cagagttggc 420
ttattgatag ccattcatgg cacttcgcat tatagtctac ttatggtttt acaggatggc 480
gtggaggcga gtcagcctca tgttgctgtt aaaatttgcc attggaatcc aggtaacata 540
agtacttacc atcaatttga tgtaaatcta ggagatggtg gtcaatgcgt ttttaatcaa 600
agattctcat tggacaccgt gttgaccgct aatgacttct atggcttcca atggactgac 660
acatatgtag acatatactt aggtggcact attactaaag tatgggttgt aaatgattgg 720
agtgttgttg aagctagcat ttcatctcat tggaatgcac ttaattatgg ttactacatt 780
caatttgtca atcgcaccac ttattacgct tacaatagta ctggtggttc aaattatacc 840
catctgcagt taactgagtg ccatactgac tactgtgctg gttatgctaa gaatgtcttt 900
gtgccaattg atggcaaaat accagaaggc ttttctttta gcaattggtt tcttttaaca 960
gataaatcca ctctagtgca aggacgtgtt cttagtagtc agcctgtttt tgtacaatgc 1020
cttagacctg taccaacatg gtctaacaat actgctgtgg tgcattttaa aaatgatgtt 1080
ttctgcccta acgtcacggc agacgttttg aggttcaatc taaattttag tgacactgat 1140
gtttatacag attcaacaac tgatgatcag ttgcatttta catttgaaga taatacaact 1200
gcatccataa cctgttacag cagtgctaat gtcactgaca accaacctgc aagtggcagc 1260
atctcacata ctccctttgt cagcaactct tacctctgtt ttgccaattt ttctcactct 1320
agtgtgagca gacagttctt aggtatacta ccaccaactg tacgagagtt tgcattcggc 1380
agagatggat ccatttttgt taatggctat aaatatttta gtttacaacc tattaagagt 1440
gttaacttct ccatcagttc agtggagaat tatggctttt ggaccatagc ctatactaac 1500
tatacagatg taatggtgga tgttaatggc acagttatta ctaggttatt ctattgtgac 1560
tcacccctca atagaattaa gtgtcaacaa ttgaagcatg agctaccaga tgggttttat 1620
tcagctagca tgcttgttaa aaaggatcta cctaagactt ttgtaactat gccacagttc 1680
tacaattgga tgaatgttac gctacatgtc gttttaaatg acattgaaaa aaaagctgac 1740
atcatcttgg ctggggctcc agaattagct tcacttgccg acatacactt tgaaatagca 1800
caggctaatg ggagtgtagt gaatgtcact agtgtgtgtg ttcaggcaag acagttggct 1860
ttattctaca agtacactag cctacaaggt ttgtacactt attctaatct ggtgcagtta 1920
caaaattatg actgtccctt ctcgccacag cagtttaata attatttgca gtttgaaact 1980
ctgtgttttg atgtaagccc agctgttgca ggttgtaagt ggtcgttagt tcatgacgtt 2040
aaatggcgca cacagtttgc aacaattact gtgtcttaca aagatggtgc aatgattact 2100
actatgccaa aggcacagct gggttttcag gacatctcca atattgttaa agatgaatgt 2160
acagattata atatatatgg ctttcaaggc acaggcatta ttagaagtac cacatcaaga 2220
ttggtcgctg gtctttacta cacctcagct agtggtgacc tcctcggatt taaaattagc 2280
actacaggtg aaattttcac cgtggtgcca tgtgacttaa cagctcaagc agcagtgatt 2340
aatgacgaaa tagtgggagc tataacagcc actaatcaaa ctgatctgtt tgagtttgta 2400
aatcacacat ggtcgagaag tgcacgcggg tcatcaccaa gcacagttaa cacctacact 2460
atgccccaat tttattacat aacaaagtgg aataatggca catcttctaa ttgcacatct 2520
gtcattacct actcctcttt tgcaatctgt aatactggtg aaattaaata tgttaatgtt 2580
acccatgttg aaattgtgga tgacagtgta ggtgttatta aacctgtttc aacaggtaat 2640
ataactatac ctaaaaattt cacagttgca gtgcaagctg aatatgttca gattcaagtc 2700
aaacctgttg ctgttgattg tgctaagtac gtttgcaatg gaaatagaca ttgccttaac 2760
ttgctaacac aatacacctc ggcttgtcaa acaatagaaa attcccttaa ccttggtgca 2820
cgccttgaat cgttaatgct taatgacatg atcacagtgt cagatcgtag tctagaattc 2880
gcaactgttg ataagtttaa tactacagct ttaggtggtg aaaaactggg tggtttatac 2940
tttgatggtc tgagtagcct attaccaccc agagtaggta tgaggtctgc tgttgaagat 3000
ctattgttca ataaagtggt aactagtggt cttggcactg tggatgatga ttataaaaag 3060
tgttcagctg gtacagatgt agctgaccta gtttgtgccc aatattacaa cggcataatg 3120
gtcttacctg gcgtcgtaga ttataataag atggccatgt atactgcatc tttaatagga 3180
ggtatggctt tgggttctat tacttcagct gtcgccgtgc ctttttctat gcaagtacag 3240
gccagactta actatgtcgc gttacaaact gatgtcctac aggaaaacca gaaaatactt 3300
gctaatgctt ttaataatgc cattggcaac attacactag ctcttggaaa agtttccaat 3360
gctattacaa ccgtctcaga tggatttaat agtatggcct cagcactgac taagattcag 3420
agtgtagtta accaacaggg tgaagcgttg agtcatctca tcagtcagtt acagaaaaac 3480
ttccaggcta ttagtagttc cattgctgaa atctacaata gattggaaaa agtggaagct 3540
gatgctcaag ttgaccgact cattactgga agattggcag cacttaatgc ctatgtggct 3600
caaactttaa ctcagtatgc tgaagtcaag gctagtagac agttggcaat ggagaaagtt 3660
aatgagtgtg tgaaatcaca gtcggatagg tatgggttct gtggaaatgg aacgcaccta 3720
ttctcactcg tcaattccgc acctgatggt ttgcttttct ttcacacagt cttgcttcct 3780
acagaatggg aagaagtgac ggcatggtca ggaatatgtg ttaatgacac ttatgcatat 3840
ctgttgaaag atttcgatca ttccattttc agctacaatg gcacgtatat ggtaactcct 3900
cgtaacatgt ttcaacctag aaaacctcag atgagtgatt tcgtgcaaat tacgagttgt 3960
gaagtgacat ttctgaacac tacacatacg acatttcagg agattgtgat tgattatatt 4020
gacatcaaca agactatcgc tgatatgctt gaacaatacc attctaatta cacaacacct 4080
gagttagact tacagctgga aatttttaat cagacaaagt taaacctcac tgcagaaata 4140
gaccaattgg aacaaagagc agacaacctc actaatatcg cacatgaact acagcagtac 4200
attgacaacc ttaataagac tattgttgac ctcgaatggc tcaacaggat tgaaacttat 4260
gtaaaatggc catggtatgt gtggctacta attggattag tagtagtctt ctgcatacca 4320
ttgttactgt tttgctgtct tagcacaggc tgctgtgggt gttttggttg tcttggaagt 4380
tgttgtcatt ctctttgcag tagacgtcaa tttgaaagtt atgaacctat tgaaaaggtt 4440
cacgttcatt gatgagctcc ctttcttgct ttccagggaa agtcccttgg tccccagacc 4500
ctaatacctg gacatgtcta aatcatgaaa ttctttgaac atctggctcc tgcctaataa 4560
agaatattta ttttcattgc aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa 4620
aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa a 4651
<210> 19
<211> 4754
<212> DNA
<213> Artificial Sequence
<400> 19
gggcgtttcc ctcttaggct gacacttgac tccttgtcta catttagctt agagagggac 60
atacataccc tggaaagtgt gggggagacg tacatagcac tgttggacct gaaggcagat 120
gatcttgtta atacttgcac tccttagcat tgctagctct gaagatgctc ctcatggtgt 180
caccttgccc cacttcaaca cgtcccataa caattccaag tttgaactta acttttacaa 240
tttcttacag acttgggaca taccaccgaa tacagaaact attctgggtg gttacttacc 300
atattgtgac catgaagaca attgtggatg gtataatttt gtttataaca acaaagtggg 360
accaaatgct aagtattcct acataaacac ccaaaacttg aacataccaa atgtccatgg 420
tgtgtacttt gatgtacgag aacacaattc tgatggtgtg tgggatcaaa ttgacagagt 480
tggcttattg atagccattc atggcacttc gcattatagt ctacttatgg ttttacagga 540
tggcgtggag gcgagtcagc ctcatgttgc tgttaaaatt tgccattgga atccaggtaa 600
cataagtact taccatcaat ttgatgtaaa tctaggagat ggtggtcaat gcgtttttaa 660
tcaaagattc tcattggaca ccgtgttgac cgctaatgac ttctatggct tccaatggac 720
tgacacatat gtagacatat acttaggtgg cactattact aaagtatggg ttgtaaatga 780
ttggagtgtt gttgaagcta gcatttcatc tcattggaat gcacttaatt atggttacta 840
cattcaattt gtcaatcgca ccacttatta cgcttacaat agtactggtg gttcaaatta 900
tacccatctg cagttaactg agtgccatac tgactactgt gctggttatg ctaagaatgt 960
ctttgtgcca attgatggca aaataccaga aggcttttct tttagcaatt ggtttctttt 1020
aacagataaa tccactctag tgcaaggacg tgttcttagt agtcagcctg tttttgtaca 1080
atgccttaga cctgtaccaa catggtctaa caatactgct gtggtgcatt ttaaaaatga 1140
tgttttctgc cctaacgtca cggcagacgt tttgaggttc aatctaaatt ttagtgacac 1200
tgatgtttat acagattcaa caactgatga tcagttgcat tttacatttg aagataatac 1260
aactgcatcc ataacctgtt acagcagtgc taatgtcact gacaaccaac ctgcaagtgg 1320
cagcatctca catactccct ttgtcagcaa ctcttacctc tgttttgcca atttttctca 1380
ctctagtgtg agcagacagt tcttaggtat actaccacca actgtacgag agtttgcatt 1440
cggcagagat ggatccattt ttgttaatgg ctataaatat tttagtttac aacctattaa 1500
gagtgttaac ttctccatca gttcagtgga gaattatggc ttttggacca tagcctatac 1560
taactataca gatgtaatgg tggatgttaa tggcacagtt attactaggt tattctattg 1620
tgactcaccc ctcaatagaa ttaagtgtca acaattgaag catgagctac cagatgggtt 1680
ttattcagct agcatgcttg ttaaaaagga tctacctaag acttttgtaa ctatgccaca 1740
gttctacaat tggatgaatg ttacgctaca tgtcgtttta aatgacattg aaaaaaaagc 1800
tgacatcatc ttggctgggg ctccagaatt agcttcactt gccgacatac actttgaaat 1860
agcacaggct aatgggagtg tagtgaatgt cactagtgtg tgtgttcagg caagacagtt 1920
ggctttattc tacaagtaca ctagcctaca aggtttgtac acttattcta atctggtgca 1980
gttacaaaat tatgactgtc ccttctcgcc acagcagttt aataattatt tgcagtttga 2040
aactctgtgt tttgatgtaa gcccagctgt tgcaggttgt aagtggtcgt tagttcatga 2100
cgttaaatgg cgcacacagt ttgcaacaat tactgtgtct tacaaagatg gtgcaatgat 2160
tactactatg ccaaaggcac agctgggttt tcaggacatc tccaatattg ttaaagatga 2220
atgtacagat tataatatat atggctttca aggcacaggc attattagaa gtaccacatc 2280
aagattggtc gctggtcttt actacacctc agctagtggt gacctcctcg gatttaaaat 2340
tagcactaca ggtgaaattt tcaccgtggt gccatgtgac ttaacagctc aagcagcagt 2400
gattaatgac gaaatagtgg gagctataac agccactaat caaactgatc tgtttgagtt 2460
tgtaaatcac acatggtcga gaagtgcacg cgggtcatca ccaagcacag ttaacaccta 2520
cactatgccc caattttatt acataacaaa gtggaataat ggcacatctt ctaattgcac 2580
atctgtcatt acctactcct cttttgcaat ctgtaatact ggtgaaatta aatatgttaa 2640
tgttacccat gttgaaattg tggatgacag tgtaggtgtt attaaacctg tttcaacagg 2700
taatataact atacctaaaa atttcacagt tgcagtgcaa gctgaatatg ttcagattca 2760
agtcaaacct gttgctgttg attgtgctaa gtacgtttgc aatggaaata gacattgcct 2820
taacttgcta acacaataca cctcggcttg tcaaacaata gaaaattccc ttaaccttgg 2880
tgcacgcctt gaatcgttaa tgcttaatga catgatcaca gtgtcagatc gtagtctaga 2940
attcgcaact gttgataagt ttaatactac agctttaggt ggtgaaaaac tgggtggttt 3000
atactttgat ggtctgagta gcctattacc acccagagta ggtatgaggt ctgctgttga 3060
agatctattg ttcaataaag tggtaactag tggtcttggc actgtggatg atgattataa 3120
aaagtgttca gctggtacag atgtagctga cctagtttgt gcccaatatt acaacggcat 3180
aatggtctta cctggcgtcg tagattataa taagatggcc atgtatactg catctttaat 3240
aggaggtatg gctttgggtt ctattacttc agctgtcgcc gtgccttttt ctatgcaagt 3300
acaggccaga cttaactatg tcgcgttaca aactgatgtc ctacaggaaa accagaaaat 3360
acttgctaat gcttttaata atgccattgg caacattaca ctagctcttg gaaaagtttc 3420
caatgctatt acaaccgtct cagatggatt taatagtatg gcctcagcac tgactaagat 3480
tcagagtgta gttaaccaac agggtgaagc gttgagtcat ctcatcagtc agttacagaa 3540
aaacttccag gctattagta gttccattgc tgaaatctac aatagattgg aaaaagtgga 3600
agctgatgct caagttgacc gactcattac tggaagattg gcagcactta atgcctatgt 3660
ggctcaaact ttaactcagt atgctgaagt caaggctagt agacagttgg caatggagaa 3720
agttaatgag tgtgtgaaat cacagtcgga taggtatggg ttctgtggaa atggaacgca 3780
cctattctca ctcgtcaatt ccgcacctga tggtttgctt ttctttcaca cagtcttgct 3840
tcctacagaa tgggaagaag tgacggcatg gtcaggaata tgtgttaatg acacttatgc 3900
atatctgttg aaagatttcg atcattccat tttcagctac aatggcacgt atatggtaac 3960
tcctcgtaac atgtttcaac ctagaaaacc tcagatgagt gatttcgtgc aaattacgag 4020
ttgtgaagtg acatttctga acactacaca tacgacattt caggagattg tgattgatta 4080
tattgacatc aacaagacta tcgctgatat gcttgaacaa taccattcta attacacaac 4140
acctgagtta gacttacagc tggaaatttt taatcagaca aagttaaacc tcactgcaga 4200
aatagaccaa ttggaacaaa gagcagacaa cctcactaat atcgcacatg aactacagca 4260
gtacattgac aaccttaata agactattgt tgacctcgaa tggctcaaca ggattgaaac 4320
ttatgtaaaa tggccatggt atgtgtggct actaattgga ttagtagtag tcttctgcat 4380
accattgtta ctgttttgct gtcttagcac aggctgctgt gggtgttttg gttgtcttgg 4440
aagttgttgt cattctcttt gcagtagacg tcaatttgaa agttatgaac ctattgaaaa 4500
ggttcacgtt cattgatgaa catctgaatc acccactgcc ttctctctag cctggaaacc 4560
caggcctaca tccataagaa gcccttaaat ccttcctctg tgttcttcaa gtgctcaggc 4620
tctgacattt catggtgtta ccctaccctg acactttaat aaagactaaa ttggtttgct 4680
ggtcaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa 4740
aaaaaaaaaa aaaa 4754
<210> 20
<211> 4528
<212> DNA
<213> Artificial Sequence
<400> 20
gtcgactttg gcacaatgat cttgttaata cttgcactcc ttagcattgc tagctctgaa 60
gatgctcctc atggtgtcac cttgccccac ttcaacacgt cccataacaa ttccaagttt 120
gaacttaact tttacaattt cttacagact tgggacatac caccgaatac agaaactatt 180
ctgggtggtt acttaccata ttgtgaccat gaagacaatt gtggatggta taattttgtt 240
tataacaaca aagtgggacc aaatgctaag tattcctaca taaacaccca aaacttgaac 300
ataccaaatg tccatggtgt gtactttgat gtacgagaac acaattctga tggtgtgtgg 360
gatcaaattg acagagttgg cttattgata gccattcatg gcacttcgca ttatagtcta 420
cttatggttt tacaggatgg cgtggaggcg agtcagcctc atgttgctgt taaaatttgc 480
cattggaatc caggtaacat aagtacttac catcaatttg atgtaaatct aggagatggt 540
ggtcaatgcg tttttaatca aagattctca ttggacaccg tgttgaccgc taatgacttc 600
tatggcttcc aatggactga cacatatgta gacatatact taggtggcac tattactaaa 660
gtatgggttg taaatgattg gagtgttgtt gaagctagca tttcatctca ttggaatgca 720
cttaattatg gttactacat tcaatttgtc aatcgcacca cttattacgc ttacaatagt 780
actggtggtt caaattatac ccatctgcag ttaactgagt gccatactga ctactgtgct 840
ggttatgcta agaatgtctt tgtgccaatt gatggcaaaa taccagaagg cttttctttt 900
agcaattggt ttcttttaac agataaatcc actctagtgc aaggacgtgt tcttagtagt 960
cagcctgttt ttgtacaatg ccttagacct gtaccaacat ggtctaacaa tactgctgtg 1020
gtgcatttta aaaatgatgt tttctgccct aacgtcacgg cagacgtttt gaggttcaat 1080
ctaaatttta gtgacactga tgtttataca gattcaacaa ctgatgatca gttgcatttt 1140
acatttgaag ataatacaac tgcatccata acctgttaca gcagtgctaa tgtcactgac 1200
aaccaacctg caagtggcag catctcacat actccctttg tcagcaactc ttacctctgt 1260
tttgccaatt tttctcactc tagtgtgagc agacagttct taggtatact accaccaact 1320
gtacgagagt ttgcattcgg cagagatgga tccatttttg ttaatggcta taaatatttt 1380
agtttacaac ctattaagag tgttaacttc tccatcagtt cagtggagaa ttatggcttt 1440
tggaccatag cctatactaa ctatacagat gtaatggtgg atgttaatgg cacagttatt 1500
actaggttat tctattgtga ctcacccctc aatagaatta agtgtcaaca attgaagcat 1560
gagctaccag atgggtttta ttcagctagc atgcttgtta aaaaggatct acctaagact 1620
tttgtaacta tgccacagtt ctacaattgg atgaatgtta cgctacatgt cgttttaaat 1680
gacattgaaa aaaaagctga catcatcttg gctggggctc cagaattagc ttcacttgcc 1740
gacatacact ttgaaatagc acaggctaat gggagtgtag tgaatgtcac tagtgtgtgt 1800
gttcaggcaa gacagttggc tttattctac aagtacacta gcctacaagg tttgtacact 1860
tattctaatc tggtgcagtt acaaaattat gactgtccct tctcgccaca gcagtttaat 1920
aattatttgc agtttgaaac tctgtgtttt gatgtaagcc cagctgttgc aggttgtaag 1980
tggtcgttag ttcatgacgt taaatggcgc acacagtttg caacaattac tgtgtcttac 2040
aaagatggtg caatgattac tactatgcca aaggcacagc tgggttttca ggacatctcc 2100
aatattgtta aagatgaatg tacagattat aatatatatg gctttcaagg cacaggcatt 2160
attagaagta ccacatcaag attggtcgct ggtctttact acacctcagc tagtggtgac 2220
ctcctcggat ttaaaattag cactacaggt gaaattttca ccgtggtgcc atgtgactta 2280
acagctcaag cagcagtgat taatgacgaa atagtgggag ctataacagc cactaatcaa 2340
actgatctgt ttgagtttgt aaatcacaca tggtcgagaa gtgcacgcgg gtcatcacca 2400
agcacagtta acacctacac tatgccccaa ttttattaca taacaaagtg gaataatggc 2460
acatcttcta attgcacatc tgtcattacc tactcctctt ttgcaatctg taatactggt 2520
gaaattaaat atgttaatgt tacccatgtt gaaattgtgg atgacagtgt aggtgttatt 2580
aaacctgttt caacaggtaa tataactata cctaaaaatt tcacagttgc agtgcaagct 2640
gaatatgttc agattcaagt caaacctgtt gctgttgatt gtgctaagta cgtttgcaat 2700
ggaaatagac attgccttaa cttgctaaca caatacacct cggcttgtca aacaatagaa 2760
aattccctta accttggtgc acgccttgaa tcgttaatgc ttaatgacat gatcacagtg 2820
tcagatcgta gtctagaatt cgcaactgtt gataagttta atactacagc tttaggtggt 2880
gaaaaactgg gtggtttata ctttgatggt ctgagtagcc tattaccacc cagagtaggt 2940
atgaggtctg ctgttgaaga tctattgttc aataaagtgg taactagtgg tcttggcact 3000
gtggatgatg attataaaaa gtgttcagct ggtacagatg tagctgacct agtttgtgcc 3060
caatattaca acggcataat ggtcttacct ggcgtcgtag attataataa gatggccatg 3120
tatactgcat ctttaatagg aggtatggct ttgggttcta ttacttcagc tgtcgccgtg 3180
cctttttcta tgcaagtaca ggccagactt aactatgtcg cgttacaaac tgatgtccta 3240
caggaaaacc agaaaatact tgctaatgct tttaataatg ccattggcaa cattacacta 3300
gctcttggaa aagtttccaa tgctattaca accgtctcag atggatttaa tagtatggcc 3360
tcagcactga ctaagattca gagtgtagtt aaccaacagg gtgaagcgtt gagtcatctc 3420
atcagtcagt tacagaaaaa cttccaggct attagtagtt ccattgctga aatctacaat 3480
agattggaaa aagtggaagc tgatgctcaa gttgaccgac tcattactgg aagattggca 3540
gcacttaatg cctatgtggc tcaaacttta actcagtatg ctgaagtcaa ggctagtaga 3600
cagttggcaa tggagaaagt taatgagtgt gtgaaatcac agtcggatag gtatgggttc 3660
tgtggaaatg gaacgcacct attctcactc gtcaattccg cacctgatgg tttgcttttc 3720
tttcacacag tcttgcttcc tacagaatgg gaagaagtga cggcatggtc aggaatatgt 3780
gttaatgaca cttatgcata tctgttgaaa gatttcgatc attccatttt cagctacaat 3840
ggcacgtata tggtaactcc tcgtaacatg tttcaaccta gaaaacctca gatgagtgat 3900
ttcgtgcaaa ttacgagttg tgaagtgaca tttctgaaca ctacacatac gacatttcag 3960
gagattgtga ttgattatat tgacatcaac aagactatcg ctgatatgct tgaacaatac 4020
cattctaatt acacaacacc tgagttagac ttacagctgg aaatttttaa tcagacaaag 4080
ttaaacctca ctgcagaaat agaccaattg gaacaaagag cagacaacct cactaatatc 4140
gcacatgaac tacagcagta cattgacaac cttaataaga ctattgttga cctcgaatgg 4200
ctcaacagga ttgaaactta tgtaaaatgg ccatggtatg tgtggctact aattggatta 4260
gtagtagtct tctgcatacc attgttactg ttttgctgtc ttagcacagg ctgctgtggg 4320
tgttttggtt gtcttggaag ttgttgtcat tctctttgca gtagacgtca atttgaaagt 4380
tatgaaccta ttgaaaaggt tcacgttcat tgatgaaaca acacaatcac aacatctcag 4440
cctaccctga gagtcgacaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa 4500
aaaaaaaaaa aaaaaaaaaa aaaaaaaa 4528

Claims (8)

1.一种用于猫冠状病毒的RNA疫苗,其特征在于,所述RNA疫苗为采用含有5’UTR、S蛋白、终止密码子、3’UTR以及polyA核酸的序列合成;
所述S蛋白选自FCoV-I型或FCoV-II型。
2.由权利要求1所述的用于猫冠状病毒的RNA疫苗,其特征在于,所述疫苗还包括纳米脂质颗粒,所述纳米脂质颗粒包裹RNA疫苗。
3.由权利要求1所述的用于猫冠状病毒的RNA疫苗,其特征在于,所述5’UTR、3’UTR的序列选取自猫源的猫血红蛋白或猫白蛋白,所选序列的同源性在50%~100%。
4.由权利要求1所述的用于猫冠状病毒的RNA疫苗,其特征在于,所述5’UTR、3’UTR分别选自六组不同的猫血红蛋白或猫血清白蛋白,其核酸序列分别为序列表SEQ ID NO.1和SEQID NO.2、SEQ ID NO.3和SEQ ID NO.4、SEQ ID NO.5和SEQ ID NO.6、SEQ ID NO.7和SEQ IDNO.8、SEQ ID NO.9和SEQ ID NO.10、SEQ ID NO.11和SEQ ID NO.12所示的六组。
5.由权利要求1所述的用于猫冠状病毒的RNA疫苗,其特征在于,所述5’UTR、3’UTR的六组序列选自GenBank中NCBI参考序列XM_023246781.1、XM_011290755.3、XM_003992859.2、XM_003992882.4、XM_003998693.4、X84842.1。
6.由权利要求1所述的用于猫冠状病毒的RNA疫苗,其特征在于,所述猫冠状病毒的S蛋白,其氨基酸序列如序列表SEQ ID NO.13所示,其核酸序列如序列表SEQ ID NO.14所示。
7.由权利要求1所述的用于猫冠状病毒的RNA疫苗,其特征在于,所述RNA疫苗的核酸序列包括如序列表SEQ ID NO.15~20所示。
8.一种用于猫冠状病毒的RNA疫苗的构建方法,其特征在于,包括如下步骤:
选取5’UTR、3’UTR、S蛋白、终止密码子、polyA核酸序列合成RNA疫苗的核酸序列构建于载体上,转染到细菌得到重组菌,将重组菌进行质粒提取得到重组质粒,将重组质粒进行酶切、转录、纯化得到RNA疫苗核酸,所述RNA疫苗的核酸序列如序列表SEQ ID NO.15~20所示;
所述S蛋白选自FCoV-I型或FCoV-II型。
CN202110531256.5A 2021-05-17 2021-05-17 一种用于猫冠状病毒的rna疫苗及其构建方法 Active CN113403329B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110531256.5A CN113403329B (zh) 2021-05-17 2021-05-17 一种用于猫冠状病毒的rna疫苗及其构建方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110531256.5A CN113403329B (zh) 2021-05-17 2021-05-17 一种用于猫冠状病毒的rna疫苗及其构建方法

Publications (2)

Publication Number Publication Date
CN113403329A true CN113403329A (zh) 2021-09-17
CN113403329B CN113403329B (zh) 2023-02-28

Family

ID=77678659

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110531256.5A Active CN113403329B (zh) 2021-05-17 2021-05-17 一种用于猫冠状病毒的rna疫苗及其构建方法

Country Status (1)

Country Link
CN (1) CN113403329B (zh)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114015702A (zh) * 2022-01-04 2022-02-08 北京科牧丰生物制药有限公司 一种用于预防猫传染性腹膜炎的mRNA疫苗及其制备方法
CN116042538A (zh) * 2022-11-24 2023-05-02 华中农业大学 一株猫冠状病毒及其应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070248949A1 (en) * 2003-12-17 2007-10-25 Agency For Science, Technology And Research Sensitive and Specific Test to Detect Sars Coronavirus
US20200138937A1 (en) * 2017-06-02 2020-05-07 Laura SHACKELTON Genetically Attenuated Nucleic Acid Vaccine
CN112076315A (zh) * 2020-08-25 2020-12-15 中国农业科学院生物技术研究所 新冠病毒s蛋白和铁蛋白亚基融合的纳米抗原颗粒、新冠疫苗及其制备方法和应用
CN112501201A (zh) * 2021-02-07 2021-03-16 无锡市人民医院 一种用于治疗非小细胞肺癌的rna疫苗及其构建方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070248949A1 (en) * 2003-12-17 2007-10-25 Agency For Science, Technology And Research Sensitive and Specific Test to Detect Sars Coronavirus
US20200138937A1 (en) * 2017-06-02 2020-05-07 Laura SHACKELTON Genetically Attenuated Nucleic Acid Vaccine
CN112076315A (zh) * 2020-08-25 2020-12-15 中国农业科学院生物技术研究所 新冠病毒s蛋白和铁蛋白亚基融合的纳米抗原颗粒、新冠疫苗及其制备方法和应用
CN112501201A (zh) * 2021-02-07 2021-03-16 无锡市人民医院 一种用于治疗非小细胞肺癌的rna疫苗及其构建方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
RAQUEL L. RUSSELL ET AL.: "Frontrunners in the race to develop a SARS-CoV-2 vaccine", 《NCR RESEARCH PRESS》 *
REIN VERBEKE ET AL.: "The dawn of mRNA vaccines: The COVID-19 case", 《JOURNAL OF CONTROLLED RELEASE》 *
SPIRO,D. ET AL.: "Feline coronavirus UU4, complete genome", 《GENBANK》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114015702A (zh) * 2022-01-04 2022-02-08 北京科牧丰生物制药有限公司 一种用于预防猫传染性腹膜炎的mRNA疫苗及其制备方法
CN116042538A (zh) * 2022-11-24 2023-05-02 华中农业大学 一株猫冠状病毒及其应用
CN116042538B (zh) * 2022-11-24 2024-05-07 华中农业大学 一株猫冠状病毒及其应用

Also Published As

Publication number Publication date
CN113403329B (zh) 2023-02-28

Similar Documents

Publication Publication Date Title
CN111592602B (zh) 一种β冠状病毒抗原、其制备方法和应用
CN112575008B (zh) 编码新型冠状病毒的结构蛋白的核酸分子以及新型冠状病毒疫苗
CN113403329B (zh) 一种用于猫冠状病毒的rna疫苗及其构建方法
CN109182380B (zh) 杆状病毒表达的猪瘟e2亚单位疫苗的制备方法及应用
CN112175086B (zh) 一种抗猪流行性腹泻病毒nsp13蛋白的单克隆抗体及应用
CN112094327A (zh) 基于新型冠状病毒rbd-sd1蛋白的截短体及其应用
GB2604692A (en) Method for preparing recombinant subunit vaccine against novel coronavirus
CN113293145A (zh) 一种麻疹病毒活载体新冠疫苗
CN113512096A (zh) 一种鲈鱼弹状病毒重组g2蛋白及其应用
JP2003525619A (ja) ウイルスコートタンパク質融合体としての植物における外来ポリペプチドの産生
CN111471701B (zh) 高效表达鹅星状病毒可溶性衣壳蛋白的orf2基因的方法及其应用
CN110845624B (zh) 一种sumo-cp融合蛋白及其制备方法以及其多克隆抗体的制备方法
CN113230394B (zh) 一种用于牛病毒性腹泻的rna疫苗及其构建方法
CN110129348B (zh) 高效制备口蹄疫病毒样颗粒的重组dna载体、应用和疫苗
CN111718958A (zh) 一种兔出血症病毒1型和2型vp60二价重组杆状病毒载体灭活疫苗及其制备方法和应用
CN111500586A (zh) 特异结合狂犬病毒l蛋白加帽区的核酸适配体及其应用
CN114702556A (zh) 一种冠状病毒rbd变异体及其应用
CN113293144B (zh) 一种重组f基因型腮腺炎病毒活载体麻疹疫苗
CN114395574A (zh) 一种猪流行性腹泻病毒融合蛋白及其编码基因与应用
CN113274491B (zh) 一种用于猪流行性腹泻的rna疫苗及其构建方法
CN111607605A (zh) 一种多价表位和亚单位疫苗的构建方法
CN113151331B (zh) SARS-ConV-2病毒S蛋白膜外BD端结构域高靶向性重组蛋白及其亚单位疫苗
CN114315984A (zh) 一种用于制备prrsv基因ii型表位缺失疫苗毒株的n蛋白表位突变标记及其应用
CN107827986B (zh) 猪O/Mya98和O/PanAsia型口蹄疫基因工程灭活疫苗
CN114703146B (zh) 一种杂交瘤细胞株及其应用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant